Volume 95, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. Lejon V, Büscher P, , 2005. Review article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop Med Int Health 10: 395403.[Crossref]
  2. Brun R, Blum J, Chappuis F, Burri C, , 2010. Human African trypanosomiasis. Lancet 375: 148159.[Crossref]
  3. Truc P, Lando A, Penchenier L, Vatunga G, Josenando T, , 2012. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease. Trans R Soc Trop Med Hyg 106: 1014.[Crossref]
  4. Priotto G, Chappuis F, Bastard M, Flevaud L, Etard J, , 2012. Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis. PLoS Negl Trop Dis 6: e1662.[Crossref]
  5. World Health Organization, 2009. WHO Includes Combination of Eflornithine and Nifurtimox in Its Essential List of Medicines for the Treatment of Human African Trypanosomiasis. Available at: http://www.who.int/neglected_diseases/disease_management/drug_combination/en/. Accessed April 28, 2016.

Data & Media loading...

  • Received : 16 Feb 2016
  • Accepted : 17 May 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error